U.S. market Closed. Opens in 1 day 8 hours 38 minutes

NNVC | NanoViricides, Inc. Stock Financials Income Statements Annual

(Stock Exchange: AMEX)
*Sign In to persist settings
Financial Year End2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-30
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue759.01K747.53K723.33K704.54K699.72K695.91K680.06K662.95K659.54KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit-759.01K-747.53K-723.33K-704.54K-699.72K-695.91K-680.06K-662.95K-659.54KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses8.52M8.94M8.11M8.74M8.00M8.66M9.33M9.60M8.86M7.06M8.67M6.59M6.08M6.43M4.94M2.82M2.79M3.08M2.60M66.00K
Selling, General & Admin3.08M2.55M2.33M2.63M3.30M2.74M4.50M4.07M3.83M3.40M3.54M2.30M1.82M2.27M1.74M1.09M1.95M2.35M1.70M35.23K
Research & Development5.44M6.39M5.78M6.11M4.70M5.92M4.83M5.53M5.03M3.66M5.13M4.29M4.27M4.16M3.20M1.73M839.24K731.81K899.89K30.77K
Other Operating Expenses0N/AN/AN/A-142.67KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-8.52M-8.94M-8.11M-8.74M-8.00M-8.66M-9.33M-9.60M-8.86M-7.06M-8.67M-6.59M-6.08M-6.43M-4.94M-2.82M-2.79M-3.08M-2.60M-66.00K
Other Expenses / Income221.97K354.89K6.74K-78.08K-5.45M235.24K761.71K-703.77K-1.87M4.86M-4.93M-2.29M-125.46K-47.71K358.27K-26.20K53.70K-36.05K-688.58KN/A
Before Tax Income-8.29M-8.59M-8.11M-8.82M-13.45M-8.42M-8.56M-10.30M-10.72M-2.20M-14.11M-8.88M-6.21M-6.48M-4.74M-2.79TN/AN/AN/AN/A
Income Tax ExpensesN/A355.83K-6.74K85.41K-49.00K-179.75K1.31M2.13M2.47M3.82M3.66M1.09M125.46K47.71K-195.74K31.93B-53.70K36.05K688.58K66.00K
Net Income-8.29M-8.59M-8.10M-8.91M-13.40M-8.24M-8.56M-10.30M-10.72M-2.20M-14.11M-8.88M-6.21M-6.48M-4.74M-2.79M-2.74M-3.12M-3.28M-66.00K
Interest ExpensesN/A938.005.12K85.41K93.67KN/A544.49K2.13M2.47M3.82M3.66M1.09MN/AN/AN/AN/AN/A90.56KN/AN/A
Basic Shares Outstanding11.87M11.63M11.53M10.90M5.62M3.59M3.25M3.01M2.88M2.83M2.56M2.29M2.14M1.99M1.86M1.71M1.67M1.60M1.48M1.43M
Diluted Shares Outstanding11.87M11.63M11.53M10.90M5.62M3.59M3.25M3.01M2.88M2.96M2.56M2.38M2.14M1.99M1.86M1.71M1.67M1.60M1.48M1.43M
EBITDA-7.76M-7.84M-7.38M-8.03M-7.30M-7.96M-8.59M-8.94M-8.20M-6.76M-8.46M-7.56M-5.99M-5.95M-4.65M-2.83M-2.73M-3.03M-2.55M-66.00K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-8.29M-8.23M-8.10M-8.74M-13.35M-8.42M-6.71M-6.05M-5.79M5.45M-6.78M-6.69M-6.08M-6.43M-4.94M31.93B-2.79M-2.99M-2.60MN/A
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙